Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT02536300 |
Title | Dose Optimization Study of Idelalisib in Follicular Lymphoma |
Recruitment | Terminated |
Gender | both |
Phase | Phase III |
Variant Requirements | No |
Sponsors | Gilead Sciences |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | ITA | FRA | ESP | CAN |